Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
Neoadjuvant ImmunotherapyNeoadjuvant Chemoimmunotherapy
Neoadjuvant Tyrosine Kinase Inhibitors
Surgical Challenges After Neoadjuvant Therapy
Adjuvant Immunotherapy in Lung Cancer: Foundational Successes and Future Directions
The Evolving Role of Adjuvant TKI in Lung Cancer: From Historical Trials to Future Strategies National Cancer Center Hospital East, Japan
Neoadjuvant, Adjuvant, or Both? Optimizing Perioperative Systemic Therapy in Lung Cancer
Adding Immunotherapy and Targeted Therapy to Chemoradiotherapy for Non-small Cell Lung Cancer
Update on Neoadjuvant and Adjuvant Trials
Advances in Systemic Therapy for Lung Cancer: Update on Biomarkers and Novel Drugs for Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC)
Role of Surgery for Patients with Metastatic Non-small Cell Lung Cancer

